Manufacturer record
Acme Generics ILLP: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Acme Generics ILLP (Himachal Pradesh) was declared Not of Standard Quality in January 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AEC2864, Thyroxine Sodium Tablets IP (THYRONORM 75 MCG TABLETS) (exp Oct 2019). RDTL Chandigarh (state lab) found it not of standard quality: Assay of Thyroxine Sodium Calculated as Anhydrous Thyroxine Sodium. Listed in the January 2019 alert.
Records by type
1 record linked to Acme Generics ILLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Thyroxine Sodium Tablets IP (THYRONORM 75 MCG TABLETS) | Batch AEC2864Mfg Nov 2017 · Exp Oct 2019 | Assay of Thyroxine Sodium Calculated as Anhydrous Thyroxine SodiumAssay | RDTL ChandigarhState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.